IFNG and neoplasm: Importantly, this increase of IFN-γ was spatially restricted to the tumor site, as no systemic increase of IFN-γ by NK cells was detected in blood or spleen, underscoring the tumor-specific immune engagement and supporting a favorable safety profile.